Dergiler / European Journal of Rheumatology / 2019 / Cilt: 6 - Sayı: 4

Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?

Sayfa
174–178
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The lack of difference between these groups may be due to the small number of patients, the retrospective study design, and the inequality of the population with respect to age and gender.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Although the frequency of metabolic syndrome has been studied separately in psoriasis, psoriatic arthritis (PsA), and rheumatoid arthritis (RA) patients, there is no study that compares the prevalence of metabolic syndrome in all three diseases.
📊
Temel Bulgular & Veri:The purpose of this study is to evaluate the relationship between metabolic syndrome (MetS) and chronic low-grade inflammatory diseases, and to determine the frequency of MetS and insulin resistance in psoriasis and PsA as compared to RA.Methods: A total of 155 patients were included in this cross-sectional study.
💡
Sonuç & Katkı:The lack of difference between these groups may be due to the small number of patients, the retrospective study design, and the inequality of the population with respect to age and gender.
🔬Tür:Araştırma Makalesi
📍Kapsam:2010 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Although the frequency of metabolic syndrome has been studied separately in psoriasis, psoriatic arthritis (PsA), and rheumatoid arthritis (RA) patients, there is no study that compares the prevalence of metabolic syndrome in all three diseases. The purpose of this study is to evaluate the relationship between metabolic syndrome (MetS) and chronic low-grade inflammatory diseases, and to determine the frequency of MetS and insulin resistance in psoriasis and PsA as compared to RA.Methods: A total of 155 patients were included in this cross-sectional study. Fifty patients who were diagnosed with psoriasis, 55 PsA patients who were diagnosed according to the CASPAR criteria, and 50 seropositive RA patients who were diagnosed according to the ACR/EULAR 2010 classifica-tion criteria were included in this study. MetS was diagnosed by the 2005 criteria of International Diabetes Federation. The cardiovascular risk factors and parameters associated with MetS were evaluated.Results: The patients’ mean age was significantly higher in the RA. MetS was determined in 33.5% of all patients and MetS and insulin resistance showed no significant difference among the three groups (psoriasis: 36%, PsA: 29%, RA: 36%; p: 0.684 and psoriasis: 70%, PsA: 64%, RA: 66%, respectively; p: 0.785). Triglyceride levels were higher in psoriasis and PsA as compared to the RA (psoriasis: 34%, PsA: 32.7%, RA: 16%, respectively; p: 0.045). The frequency of hypertension was 38% in the RA, which was higher than PsA and psoriasis (p: 0.011).Conclusion: In all three groups, the prevalence of MetS was shown to be higher than the general population. The lack of difference between these groups may be due to the small number of patients, the retrospective study design, and the inequality of the population with respect to age and gender.

🔖

Bu Makaleye Atıf Yap

YAZICI, A., ÖZKUL, Ö., AKTÜRK, A. S., KARADAĞ, D. T., IŞIK, Ö. O., TEKEOĞLU, S., CEFLE, A. (2022). Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?. European Journal of Rheumatology, Cilt: 6 - Sayı: 4, 174–178. https://ajindex.com/articles/511585

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Griffiths CE, van de Kerkhof P, Czarnecka-Oper-acz M. Psoriasis and Atopic Dermatitis. Derma-tol Ther (Heidelb) 2017
  2. [CrossRef] 2. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Time trends in epide-miology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol 2009
  3. [CrossRef] 3. Kerschbaumer A, Fenzl KH, Erlacher L, Aletaha D. An overview of psoriatic arthritis -epidemi-ology, clinical features, pathophysiology and novel treatment targets. Wien Klin Wochenschr 2016
  4. [CrossRef] 4. Salihbegovic EM, Hadzigrahic N, Cickusic AJ. Psoriasis and Metabolic Syndrome. Medical Ar-chives 2015
  5. [CrossRef ]5. Costa L, Caso F, Ramonda R, Del Puente A, Can-tarini L, Darda MA, et al. Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthri-tis patients: an observational study. Immunol Res 2015
  6. [CrossRef] 6. Bostoen J, Van Praet L, Brochez L, Mielants H, Lambert J. A cross-sectional study on the peva-lence of metabolic syndrome in psoriasis com-pared to psoriatic arthritis. J Eur Acad Dermatol Venereol 2014
  7. [CrossRef] 7. Haroon M, Gallagher P, Heffernan E, Fitzgerald O. High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is asso-ciated with the severity of underlying disease. J Rheumatol 2014
  8. [CrossRef] 8. Raychaudhuri SK, Chatterjee S, Nguyen C, Kaur M, Jialal I, Raychaudhuri SP. Increased Preva-lence of the Metabolic Syndrome in Patients with Psoriatic Arthritis. Metab Syndr Relat Dis-ord 2010
  9. [CrossRef] 9. Sharma A, Gopalakrishnan D, Kumar R, Vijay-vergiya R, Dogra S. Metabolic Syndrome in Pso-riatic Artrhritis patients: A Cross Sectional Study. Int J Rheum Dis 2013
  10. [CrossRef] 10. Dessein PH, Tobias M, Veller MG. Metabolic syn-drome and subclinical atherosclerosis in rheu-matoid arthritis. J Rheumatol 2006
  11. Özmen M, Yersal Ö, Öztürk S, Soysal D, Köseeoğ-lu MH. Prevalence of the metabolic syndrome in rheumatoid arthritis. Eur J Rheumatol 2014
  12. [CrossRef] 12. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. CASPAR Study Group. Classifi-cation criteria for Psoriatic Arthritis: development of new criteria from a large international study. Arthri-tis Rheum 2006
  13. 73 [CrossRef] 13. Aletaha D, Neogi T, Silman AJ, Funovits J, Fel-son DT, Bingham CO 3rd, et al. 2010